CIBC World Keeps 'Strong Buy' on XOMA
Analyst Matthew Geller believes the announcement of a delay in a new drug filing could end up being net positive for the pharmaceutical concern
CIBC World reiterates strong buy on XOMA Ltd. (XOMA ).
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: